Study Protocol of Regorafenib Escalation for Colorectal Cancer (RECC): A Phase II Multicenter Clinical Trial of the Efficacy and Safety of Regorafenib Dose Escalation Therapy as the Third or Fourth Line Therapy for Unresectable/Recurrent Colorectal Cancer

Recurrent Colorectal Cancer ◽

Escalation Therapy ◽

The Third ◽

A Trial Protocol of Biweekly TAS-102 and Bevacizumab as Third-Line Chemotherapy for Advanced/Recurrent Colorectal Cancer: A Phase II Multicenter Clinical Trial (The TAS-CC4 Study)

Journal of the Anus Rectum and Colon ◽

10.23922/jarc.2018-043 ◽

2019 ◽

Vol 3 (3) ◽

pp. 136-141 ◽

Cited By ~ 1

Author(s):

Yoichiro Yoshida ◽

Takeshi Yamada ◽

Hiroshi Matsuoka ◽

Hiromichi Sonoda ◽

Atsuko Fukazawa ◽

...

Keyword(s):

Colorectal Cancer ◽

Clinical Trial ◽

Phase Ii ◽

Trial Protocol ◽

Recurrent Colorectal Cancer ◽

Third Line ◽

Line Chemotherapy

Efficacy and safety of nimotuzumab in addition to radiotherapy and temozolomide for cerebral glioblastoma: a phase II multicenter clinical trial

Journal of Cancer ◽

10.7150/jca.30123 ◽

2019 ◽

Vol 10 (14) ◽

pp. 3214-3223 ◽

Cited By ~ 6

Author(s):

Xiao-Jing Du ◽

Xian-Ming Li ◽

Lin-Bo Cai ◽

Jian-Cong Sun ◽

Si-Yang Wang ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Efficacy And Safety ◽

Multicenter Clinical Trial

Efficacy and safety findings from a phase II study of capecitabine (X) as first-line therapy in Japanese patients (pts) with advanced/metastatic colorectal cancer (MCRC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.3693 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 3693-3693 ◽

Cited By ~ 1

Author(s):

K. Shirao ◽

T. Doi ◽

K. Hatake ◽

Y. Arai ◽

K. Yamaguchi ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Japanese Patients ◽

Efficacy And Safety ◽

First Line ◽

First Line Therapy ◽

Cetuximab Plus Mfolfox-6 As First-Line Therapy for Unresectable Liver Metastasis from Colorectal Cancer: An Open, Non-Randomized, Multicenter Phase II Clinical Trial

Annals of Oncology ◽

10.1016/s0923-7534(20)33115-x ◽

2012 ◽

Vol 23 ◽

pp. ix217

Author(s):

S. Cai ◽

W. Zhang ◽

W. Li ◽

Y. Xu ◽

W. Gu ◽

...

Keyword(s):

Colorectal Cancer ◽

Clinical Trial ◽

Liver Metastasis ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

First Line ◽

Unresectable Liver Metastasis ◽

First Line Therapy ◽

Multicenter Phase ◽

Biweekly TAS-102 and bevacizumab as a third-line chemotherapy for metastatic colorectal cancer: A phase II multicenter clinical trial (TAS-CC4 study)

Annals of Oncology ◽

10.1093/annonc/mdz246.098 ◽

2019 ◽

Vol 30 ◽

pp. v235

Author(s):

Y. Yoshida ◽

T. Yamada ◽

H. Matsuoka ◽

K. Hirata ◽

H. Kuramochi ◽

...

Keyword(s):

Colorectal Cancer ◽

Clinical Trial ◽

Phase Ii ◽

Third Line ◽

Line Chemotherapy

Phase II Study to Evaluate the Efficacy and Safety of Fruquintinib Plus Sintilimab as Third-line Therapy for Colorectal Cancer

Case Medical Research ◽

10.31525/ct1-nct04179084 ◽

2019 ◽

Author(s):

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Efficacy And Safety ◽

Line Therapy ◽

Third Line Therapy ◽

Third Line

A Phase II Clinical Study of mFOLFOX6 Plus Bevacizumab as First-line Therapy for Japanese Advanced/Recurrent Colorectal Cancer Patients

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyt127 ◽

2013 ◽

Vol 43 (11) ◽

pp. 1080-1086 ◽

Cited By ~ 17

Author(s):

T. Nishina ◽

Y. Takano ◽

T. Denda ◽

H. Yasui ◽

K. Takeda ◽

...

Keyword(s):

Colorectal Cancer ◽

Clinical Study ◽

Cancer Patients ◽

Phase Ii ◽

Recurrent Colorectal Cancer ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Phase Ii Clinical Study ◽

Colorectal Cancer Patients

698 PUBLICATION Efficacy and safety findings from a phase II study of capecitabine (X) as first-line therapy in Japanese patients (pts) with metastatic colorectal cancer (MCRC): comparison with published Western data

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)80993-0 ◽

2005 ◽

Vol 3 (2) ◽

pp. 198

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Japanese Patients ◽

Efficacy And Safety ◽

First Line ◽

First Line Therapy ◽

3046 POSTER A randomized, open-label phase II study evaluating the efficacy and safety of FOLFOX6 + Cetuximab versus FOLFIRI + Cetuximab as first-line therapy in patients with metastatic colorectal cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)70974-6 ◽

2007 ◽

Vol 5 (4) ◽

pp. 249 ◽

Cited By ~ 1

Author(s):

T.E. Ciuleanu ◽

W. Scheithauer ◽

G. Kurteva ◽

J. Ocvirk ◽

I. Koza ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Efficacy And Safety ◽

First Line ◽

Open Label ◽

First Line Therapy ◽

Line Therapy ◽

Open Label Phase

8702 ORAL A Phase II, Multicenter, Clinical Trial to Evaluate the Efficacy and Safety of Bevacizumab Alone in Japanese Patients With Recurrent Malignant Glioma

European Journal of Cancer ◽

10.1016/s0959-8049(11)72253-5 ◽

2011 ◽

Vol 47 ◽

pp. S575

Author(s):

M. Matsutani ◽

R. Nishikawa ◽

H. Kobayashi ◽

S. Takano ◽

N. Shinoura ◽

...

Keyword(s):

Clinical Trial ◽

Malignant Glioma ◽

Phase Ii ◽

Japanese Patients ◽

Efficacy And Safety ◽

Recurrent Malignant Glioma